妊娠前出血症と関連した代謝プロファイルとその重症度:コロンビアの妊婦における症例対照研究
Claudia C Colmenares-Mejia1,2,3, Paula K Bautista-Nino4, Doris C Quintero-Lesmes4
1Basic Science School, Health Faculty, Universidad del Valle, Cali, Colombia. claudiacolmenares@fcv.org.
Scientific reports
|August 27, 2025
まとめ
超大量のHDL粒子は子宮前出血症のリスクが低く,超大量のVLDL粒子は高いリスクと関連しており,潜在的な治療目標を提供している.
科学分野:
- 脂質代謝
- 産婦人科
- 心血管科学
背景:
- 妊娠前出血症は 妊娠中の重大な合併症です
- 脂質タンパク質の代謝は心臓血管の健康に役割を果たします.
- 妊娠前出血症における特定のリポプロテインのプロファイルは完全に理解されていません.
研究 の 目的:
- 脂質タンパク質の粒子の大きさと妊娠前出血症のリスクとの関連を調査する.
- 妊娠前出血症のリスク評価のための潜在的なバイオマーカーを特定する.
主な方法:
- 脂質タンパク質の粒子の大きさを測定するために,核磁気共振 (NMR) スペクトロスコーピーを利用した.
- 異なる脂質タンパク質サブクラス (HDL,VLDL) と妊娠前出血症の発生率との関連を分析した.
主要な成果:
- 高密度脂質 (HDL) の超大粒 (14. 3 nm) は妊娠前出血症と逆相関を示した.
- 非常に大きい (≥75 nm) と非常に大きい (64 nm) 非常に低密度脂質 (VLDL) の粒子は,妊娠前出血症のリスクの増加と関連していました.
結論:
- 特定のリポプロテイン関連の代謝シグネチャーは,妊娠前出血症と関連しています.
- 特定のリポプロテインサブクラスは,妊娠前出血症におけるリスク評価と治療的介入のターゲットとして機能する.
さらに関連する動画
14:56Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
4.7K
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
915
関連する概念動画
01:07Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
01:20Inborn Errors of Metabolism
1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:25Jaundice
35
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
35